Got question from reading this :
The company has successfully completed a mechanism of action study for synthetic cannabidiol in skin disease, with positive data announced in June 2019 and is developing a pipeline of product candidates that leverages the antimicrobial properties of cannabidiol, with first products planned to enter clinic in 2H CY2019
have the products enter the clinic yet ?? or is it going to before end of year?
Got question from reading this : The company has successfully...
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $547.3M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 35.5¢ | 34.0¢ | $4.248M | 12.20M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 544087 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 321500 | 2 |
View Market Depth
| Last trade - 15.59pm 28/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |